Exo Inc. (formerly MEDO DX Pte.)

Santa Clara, California, United States All United States companies → — Founded 2015

Imaging AI Specialist Medical Device / Hardware Point-of-Care Diagnostics

Endocrinology Otolaryngology (ENT) Radiology

Endocrinology & Metabolic AI Radiology & Imaging AI

Series C

Claim this company

Products

MEDO-Thyroid

Exo Inc. (formerly MEDO DX Pte.)

Endocrinology & Metabolic AI

MEDO-Thyroid is an AI-powered software that streamlines thyroid ultrasound workflow by automatically analyzing images, measuring structures, and characterizing nodules using TI-RADS to generate interactive reports.

Contact for pricing

See all 1 product →

About Exo Inc. (formerly MEDO DX Pte.)

Exo Inc., formerly known as MEDO DX Pte., is a pioneering healthcare AI company focused on making high-performance, handheld ultrasound technology accessible and easy to use for medical professionals worldwide. The company develops a comprehensive point-of-care ultrasound ecosystem that integrates solid-state transducers, cloud connectivity, and advanced artificial intelligence algorithms. This platform, including products like Exo Iris and Exo Works, is designed to enable clinicians to perform diagnostic-quality cardiac, lung, and abdominal scans affordably and efficiently, even in settings where specialized ultrasound expertise may be limited.

Exo’s technology aims to decentralize healthcare by empowering a wider range of caregivers to utilize ultrasound for faster and more accurate diagnoses and treatment decisions. Their AI-powered solutions, such as AI Platform (AIP001), Bladder AI (AIBV01), Strain AI (SAI001), and Lung AI (LAI001), assist in quantifying and reporting critical clinical parameters, detecting and measuring features in ultrasound images, and streamlining workflow for conditions like thyroid nodules, developmental dysplasia of the hip, and lung issues. By simplifying image acquisition and interpretation, Exo’s platform allows less-trained personnel to conduct high-quality exams, ultimately improving patient outcomes by facilitating real-time critical decisions.

Focus Areas

handheld ultrasound point-of-care ultrasound (POCUS) AI for medical imaging medical devices health diagnostics clinical workflow automation medical imaging software

Business Intelligence

Technology

cloud-native, edge computing, AI operating system, silicon-based ultrasound transducer chips

What Physicians Need to Know

Point-of-Care Ultrasound (POCUS) Systems

Exo Inc. specializes in high-performance, handheld ultrasound devices like the Exo Iris®, designed for bedside imaging. These devices integrate AI applications for real-time scanning assistance and are built on advanced silicon technology, offering a portable and affordable alternative to traditional cart-based systems.

AI-Driven Ultrasound Image Interpretation

Exo Inc. develops FDA-cleared AI applications that assist in interpreting ultrasound images for various conditions, including cardiac and lung assessments, bladder volume quantification, and detection of pleural effusion and consolidation/atelectasis.

Handheld Ultrasound Devices

The company's flagship product, Exo Iris®, is a pocket-sized, handheld ultrasound probe that delivers high-performance medical imaging. It's designed for ease of use, enabling healthcare professionals to make critical, real-time decisions.

Clinical Workflow Automation

Exo Works™ is a cloud-based POCUS workflow and documentation platform that centralizes image storage, automates documentation and QA workflows, and provides analytics. It aims to simplify the process of documenting, reviewing, billing, and managing quality assurance for ultrasound exams.

POCUS Education and Training

Exo offers on-demand educational resources and coached training for clinicians through its Exo U library, including short, instructional videos. The AI-powered ultrasound device, Exo Iris®, also acts as a POCUS coach, guiding users in image acquisition and interpretation.

Cardiac Imaging

Exo's AI applications include tools for cardiac assessment, such as quantifying left ventricular ejection fraction (LVEF) and stroke volume, aiding in the diagnosis and management of heart failure.

Lung Imaging

The company provides AI-powered tools for lung assessment, including the reliable detection of B-lines for pulmonary edema and the identification of pleural effusion and consolidation/atelectasis.

Fluid Management

Exo's AI-based tools can assess fluid status, including IVC collapsibility analysis, and quantify bladder volume from ultrasound images.

Population Health

By making high-quality, affordable, and easy-to-use medical imaging accessible, Exo aims to improve healthcare delivery and patient outcomes on a broader scale, particularly in rural and under-resourced settings.

Diagnostic Equipment, Healthtech, Life Sciences

Exo is recognized as a health information and devices company, pioneering advancements in medical imaging through its high-performance handheld ultrasound platform and AI. They were included in TIME's List of the World's Top HealthTech Companies 2026.

Physician Tip

Exo's handheld ultrasound devices with integrated AI offer physicians immediate, on-site diagnostic capabilities, potentially accelerating diagnosis and treatment, especially in emergency, acute care, and remote settings. The AI-driven interpretation tools can enhance accuracy and reduce operator dependence, making POCUS more accessible to a wider range of clinicians. The cloud-based workflow solutions streamline documentation and compliance, freeing up time for patient care. For those new to POCUS, the embedded educational resources and AI-guided scanning can significantly aid in skill acquisition and confidence. Physicians can leverage the cardiac and lung AI for rapid assessments of conditions like heart failure and pulmonary edema, and the bladder AI for quick volume quantification. The device's portability allows for greater flexibility in patient care pathways.

Exo Works, the company's POCUS workflow solution, is device-agnostic and designed to integrate with various point-of-care ultrasound devices, as well as common Electronic Medical Record (EMR) and hospital PACS systems. It supports DICOM (for modality worklist, PACS/VNA) and HL7 (for ADT, ultrasound orders, exam results) for seamless connectivity with hospital IT infrastructure, and offers SAML single sign-on and Active Directory.

Products by Exo Inc. (formerly MEDO DX Pte.)

1 product in the directory

MEDO-Thyroid

Exo Inc. (formerly MEDO DX Pte.)

Endocrinology & Metabolic AI

Contact for pricing

What the Web Says

Exo Inc., formerly MEDO DX Pte., is a health information and medical devices company focused on modernizing medical imaging through handheld ultrasound and AI. They acquired Medo AI to integrate its technology, aiming to make ultrasound imaging more accessible and easier to use for caregivers. While the company culture is generally viewed positively by a high percentage of employees, there are concerns regarding work-life balance, pay, job security, and management.

Overall: Mixed

Strengths

High percentage of employees proud to work there and feel welcome
Management is often seen as honest and ethical
Facilities contribute to a good working environment
Product aims to make medical imaging high-quality, affordable, and easy-to-use
AI-enabled point-of-care ultrasound (POCUS) designed to accelerate diagnosis and improve patient care
Integration of Medo's AI makes ultrasound imaging faster and simpler, requiring less expertise

Limitations

Low ratings for work-life balance
Concerns about pay and benefits
Issues with job security and advancement
Negative feedback on management
Some employees describe the environment as inaccurate and unstable
One review mentions the company not being worth working for due to low pay

Based on reviews from: Indeed.com, Great Place To Work®, Business Wire, MobiHealthNews, Exo AI

Last updated: 2026-10-22

Videos

News, demos, and interviews about Exo Inc. (formerly MEDO DX Pte.).

Loading videos...

Videos load interactively. If none appear, search YouTube for Exo Inc. (formerly MEDO DX Pte.) →

View all on YouTube

Press & Coverage

HIT Consultant

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

Exo announced its FDA-cleared cardiac and lung AI applications are now available on Exo Iris™, its high-performance handheld ultrasound device, aiming to accelerate diagnosis for heart failure patients.

2024-04

MedTech Dive

Exo adds FDA-cleared AI tools to handheld ultrasound system

Exo has made new artificial intelligence tools available on its Iris handheld ultrasound system, with FDA clearance for analyzing ultrasound images of the heart and lung, particularly beneficial for rural and under-resourced settings.

2024-04

Medical Device Network

Exo lands FDA clearance for two AI lung disease ultrasound apps

Exo obtained 510(k) clearance from the US FDA for two AI-based apps that detect pleural effusion and consolidation/atelectasis with its Exo Iris point-of-care ultrasound (POCUS) device.

2025-06

exo.inc

Exo® Acquires Medo AI to Make Medical Imaging as Easy as Snapping a Smartphone Photo

Exo announced its acquisition of Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use by integrating Medo's proprietary Sweep AI™ technology into its ultrasound platform.

2022-07

MobiHealthNews

Ultrasound devicemaker Exo acquires AI developer Medo

Exo acquired Medo, which offers AI tools for ultrasound imaging, bringing two FDA-cleared algorithms to the combined business to help healthcare workers with less ultrasound expertise.

2022-07

The Imaging Wire

Exo took a big step towards making its handheld ultrasounds easier to use and adopt, acquiring AI startup Medo AI.

Exo acquired AI startup Medo AI, planning to integrate Medo's Sweep AI technology into its ultrasound platform to streamline POCUS adoption among clinicians.

2022-07

Radiology Business

Samsung invests in ultrasound imaging startup Exo, which has now raised $320M.

Samsung has inked a strategic collaboration with ultrasound imaging startup Exo, which has already raised over $320 million in funding from some big-name investors.

2025-05

Private Equity International

Exo rakes in $220m Series C

Exo, a health information and devices company, secured $220 million in Series C funding, led by RA Capital Management.

2021-07

Frequently Asked Questions

What specific POCUS systems and handheld ultrasound devices does Exo Inc. offer, and how do they compare to traditional cart-based systems?

Exo Inc. offers the Exo Iris, a handheld ultrasound device designed for point-of-care use. It leverages a proprietary piezoelectric micromachined ultrasound transducer (PMUT) technology to deliver high-quality imaging in a compact form factor. Unlike traditional cart-based systems, the Exo Iris is highly portable and integrates with AI for real-time image interpretation, aiming to improve accessibility and efficiency in various clinical settings.

How does Exo Inc.'s AI-driven ultrasound image interpretation technology enhance diagnostic accuracy and clinical workflow for physicians?

Exo Inc.'s AI-driven ultrasound image interpretation, powered by its Exo Works software, provides real-time guidance and automated measurements to assist physicians in interpreting ultrasound images. This technology aims to reduce inter-operator variability, improve diagnostic accuracy, and streamline clinical workflows by automating tasks such as image labeling and report generation, allowing physicians to focus more on patient care.

What kind of education and training programs does Exo Inc. provide to help healthcare professionals effectively integrate POCUS into their practice?

Exo Inc. offers educational resources and training through its Exo Works platform, which includes integrated POCUS education. These programs are designed to help healthcare professionals, from novices to experienced users, effectively integrate POCUS into their practice by providing guidance on image acquisition, interpretation, and clinical application.

What are the pricing models for Exo Inc.'s POCUS systems and AI software, and what kind of ongoing support and maintenance can healthcare administrators expect?

While specific pricing models are not publicly detailed, Exo Inc. aims to make its technology accessible, suggesting a focus on value for healthcare providers. Healthcare administrators can expect ongoing support and maintenance for both the Exo Iris device and the Exo Works software, ensuring optimal performance and addressing any technical issues.

How does Exo Inc. address data privacy, security, and regulatory compliance for its AI-driven ultrasound solutions in a healthcare setting?

Exo Inc. prioritizes data privacy and security within its Exo Works platform, which is designed to be HIPAA compliant. The company adheres to stringent regulatory standards for medical devices and AI in healthcare, ensuring that patient data is protected and that its solutions meet the necessary safety and efficacy requirements.

What is Exo Inc.'s strategy for expanding its POCUS technology into areas like cardiac imaging, lung imaging, and fluid management, and how does this impact population health initiatives?

Exo Inc.'s POCUS technology, particularly the Exo Iris and Exo Works, is designed for broad application across various clinical areas, including cardiac and lung imaging, and fluid management. By providing accessible and intelligent ultrasound, Exo aims to improve early diagnosis, enhance chronic disease management, and support population health initiatives by making advanced diagnostic tools available at the point of care.

What partnerships has Exo Inc. established to further its reach and integrate its technology within the broader healthtech and life sciences ecosystems?

Exo Inc. has formed strategic partnerships to expand its reach and integrate its technology. For example, it has partnered with organizations like the American College of Emergency Physicians (ACEP) to advance POCUS education and adoption. These collaborations help to embed Exo's solutions within clinical workflows and foster innovation in the healthtech and life sciences sectors.

Related Companies

Suggest an Edit → | Report an issue